This inventor holds 1 USPTO granted patent. Top assignees: Hoffmann-La Roche Inc., The University of Texas System. Active years: 1989.
Company Filing History:
1 out of 5,024 
1 out of 5,633 
Years Active: 1989
Title: Joseph E Zerwekh: Innovator in Hypercalcitriolemic Treatment
Introduction
Joseph E Zerwekh is a notable inventor based in Ovilla, Texas. He has made significant contributions to the field of medicine, particularly in the treatment of hypercalcitriolemic disease states. His innovative approach has led to the development of a unique method that utilizes a specific compound for effective treatment.
Latest Patents
Zerwekh holds a patent for his invention titled "25S,26-dihydroxycholecalciferol in the treatment of hypercalcitriolemic." This patent describes a method that involves administering an effective amount of 25S,26-dihydroxycholecalciferol to a host in need of such treatment. His work in this area has the potential to improve the quality of life for individuals suffering from this condition.
Career Highlights
Throughout his career, Zerwekh has been associated with prominent organizations, including the University of Texas System and Hoffmann-La Roche Inc. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research.
Collaborations
Zerwekh has worked alongside notable colleagues such as Milan R Uskokovic and Charles Y Pak. These collaborations have contributed to the advancement of his research and the successful development of his patent.
Conclusion
Joseph E Zerwekh's contributions to the treatment of hypercalcitriolemic disease states highlight his innovative spirit and dedication to improving healthcare. His patent and collaborations reflect his commitment to advancing medical science.